Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(7%)
Results Posted
50%(4 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_4
8
53%
Ph phase_2
2
13%
Ph not_applicable
5
33%

Phase Distribution

0

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution15 total trials
Phase 2Efficacy & side effects
2(13.3%)
Phase 4Post-market surveillance
8(53.3%)
N/ANon-phased studies
5(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(8)
Terminated(1)
Other(4)

Detailed Status

Completed8
unknown4
Recruiting1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (13.3%)
Phase 48 (53.3%)
N/A5 (33.3%)

Trials by Status

recruiting17%
terminated17%
completed853%
not_yet_recruiting17%
unknown427%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT06777966Phase 4

Nebulized Versus Intravenous Tranexamic Acid on Surgical Field Quality in Patients Undergoing Endoscopic Sinus Surgeries

Recruiting
NCT06515535Not Applicable

Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa

Not Yet Recruiting
NCT05686005Phase 4

Tranexamic Acid in Functional Endoscopic Sinus Surgery

Completed
NCT05841251Not Applicable

Phenylephrine Versus Tranexamic Acid to Control Bleeding in Patients Undergoing Inferior Turbinoplasty by Coblation

Unknown
NCT03825939Phase 4

Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty

Terminated
NCT03570710Not Applicable

Reducing Blood Loss During Cesarean Hysterectomy for Placenta Accreta Spectrum

Completed
NCT03706339Not Applicable

Reducing Blood Loss During Cesarean Section by Topical Versus IV Tranexamic Acid

Completed
NCT04358965Phase 4

Tranexamic Acid Versus Vaginal Misoprostol in Abdominal Myomectomy

Unknown
NCT04357002Phase 4

Intravenous Tranexamic Acid Versus Vaginal Dinoprostone in Abdominal Myomectomy

Unknown
NCT04357015Phase 4

Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy

Unknown
NCT02540226Phase 4

Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement

Completed
NCT01940523Phase 4

Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical

Completed
NCT03244423Phase 2

Tranexamic Acid in Cyanotic Heart Defects

Completed
NCT02233101Not Applicable

Oral vs. Intravenous TXA Study Proposal: TJA

Completed
NCT02829346Phase 2

Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15